Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Anaptysbio (ANAB) over the last 5 years, with Q3 2025 value amounting to $3.3 million.

  • Anaptysbio's Treasury Shares rose 5742.59% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 5742.59%. This contributed to the annual value of $1.2 million for FY2024, which is 4220.56% down from last year.
  • Per Anaptysbio's latest filing, its Treasury Shares stood at $3.3 million for Q3 2025, which was up 5742.59% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Treasury Shares peaked at $3.3 million during Q3 2025, and registered a low of $292898.0 during Q1 2025.
  • Its 4-year average for Treasury Shares is $1.6 million, with a median of $1.6 million in 2023.
  • As far as peak fluctuations go, Anaptysbio's Treasury Shares skyrocketed by 29720.53% in 2024, and later crashed by 8621.15% in 2025.
  • Anaptysbio's Treasury Shares (Quarter) stood at $1.0 million in 2022, then soared by 106.47% to $2.1 million in 2023, then tumbled by 42.21% to $1.2 million in 2024, then soared by 172.39% to $3.3 million in 2025.
  • Its Treasury Shares stands at $3.3 million for Q3 2025, versus $2.6 million for Q2 2025 and $292898.0 for Q1 2025.